Soluble CD138/Syndecan-1 Increases in the Sera of Patients with Moderately Differentiated Bladder Cancer

Publisher： Karger

E-ISSN： 1423-0399|94|4|472-478

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.94, Iss.4, 2014-08, pp. : 472-478

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential Value of Soluble Intercellular Adhesion Molecule-1 in the Serum of Patients with Bladder Cancer

By  

Urologia Internationalis, Vol. 70, Iss. 3, 2003-04 ,pp. : 167-171

Karger

Access to resources Recommend Favorite

Soluble CD44 Variant 6 as a Prognostic Indicator in Patients with Colorectal Cancer

By  

Oncology, Vol. 56, Iss. 3, 1999-04 ,pp. : 232-238

Karger

Access to resources Recommend Favorite

Prognostic Value of Syndecan-1 Expression in Breast Cancer

By  

Oncology, Vol. 67, Iss. 1, 2004-10 ,pp. : 11-18

Karger

Access to resources Recommend Favorite

Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 31, Iss. 3, 2015-03 ,pp. : 307-314

John Wiley & Sons Inc

Access to resources Recommend Favorite

Syndecan-1 Expression – A Novel Prognostic Marker in Pancreatic Cancer

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 97-106

Karger

Access to resources Recommend Favorite